Study published online today in the Journal of Clinical Investigation shows that readdition of SPARC to bladder tumors stops metastasis to lungs, where the cancer is frequently fatal
(PRWeb January 16, 2013)
Read the full story at http://www.prweb.com/releases/2013/1/prweb10330748.htm